
Strategic and tactical experience in both device and regenerative medicine platforms, including drug/device combination products, cell-based implants, allografts, and biomaterials
CMC
Business Analytics
Jim is a seasoned medical device/biotechnology executive with strategy and tactical experience spanning both the device and regenerative medicine platforms, including drug/device combination products, cell-based implants, allografts, and biomaterials. He has extensive experience with early-stage start-ups, emerging companies, Class III medical devices, and PMAs. His expertise spanning product development, marketing and business development, provides clients with extremely valuable cross-functional insights for our client partners. Prior to joining BCVG, Jim was Senior Director at BioMimetic Therapeutics (acquired by Wright Medical) where he had responsibility for product development and commercial strategy for Augment Bone Graft. Jim is a graduate of the University of Michigan (MSE, Biomedical Engineering; BS, Cell and Molecular Biology) and Santa Clara University (MBA, Finance).
Jim is a seasoned medical device/biotechnology executive with strategy and tactical experience spanning both the device and regenerative medicine platforms, including drug/device combination products, cell-based implants, allografts, and biomaterials. He has extensive experience with early-stage start-ups, emerging companies, Class III medical devices, and PMAs. His expertise spanning product development, marketing and business development, provides clients with extremely valuable cross-functional insights for our client partners. Prior to joining BCVG, Jim was Senior Director at BioMimetic Therapeutics (acquired by Wright Medical) where he had responsibility for product development and commercial strategy for Augment Bone Graft. Jim is a graduate of the University of Michigan (MSE, Biomedical Engineering; BS, Cell and Molecular Biology) and Santa Clara University (MBA, Finance).